Clinical Trials Browser

Phase 1 × ridaforolimus × Tumor-Agnostic × Clear all

NCT00694083 2024-05-21

Study of Ridaforolimus (MK-8669) in Participants With Solid Tumors (MK-8669-003)(COMPLETED)

Phase 1 Completed

Neoplasms

NCT00874731 2019-05-06

MK-8669-037

Phase 1 Completed

23 enrolled 14 charts

Neoplasm Metastasis